Sunho Biologics

Key Takeaways: With no product or licensing revenue, Sunho Biologics has been piling up debts from high R&D spending The company only just crept over the listing threshold after a fund-raising round in May boosted its market capitalization By Molly Wen Hong Kong’s IPO market has been...